Secukinumab retention rate is greater in patients with psoriatic arthritis presenting with axial involvement

• Главные авторы: G. Adami (Автор), L. Idolazzi (Автор), C. Benini (Автор), E. Fracassi (Автор), A. Carletto (Автор), O. Viapiana (Автор), D. Gatti (Автор), M. Rossini (Автор), A. Fassio (Автор)
• Формат: ‌
• Опубликовано: PAGEPress Publications, 2023-05-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Psoriatic arthritis (PsA) is an inflammatory disease characterized by peripheral and axial involvement. Biological disease-modifying antirheumatic drugs (bDMARDs) are the mainstream treatment for PsA and bDMARDs retention rate is a proxy for the drug's overall effectiveness. However, it is uncl...